What may GLP1 receptor agonists contribute to the treatment of patients with non-alcoholic fatty liver disease?

Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva
Francisco Javier Escalada San Martín

Abstract

Non-alcoholic fatty liver disease (NAFLD) poses a challenge to health services both in developed and developing countries, with a significant increase in incidence and prevalence that is related to the currently increased prevalence of obesity. Besides an acknowledged higher risk for advanced liver disease (cirrhosis, hepatocellular carcinoma), morbidity and mortality from cardiovascular disease both increase in people with NAFLD. As a matter of fact, NAFLD is a cardiovascular risk factor.

References

Jun 10, 2015·JAMA : the Journal of the American Medical Association·Mary E Rinella
Sep 24, 2015·Journal of Hepatology·Matthew J ArmstrongJeremy W Tomlinson
Feb 3, 2016·Diabetes, Obesity & Metabolism·J P H WildingC W le Roux
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
Jun 14, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN LEADER Trial Investigators
Sep 17, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN SUSTAIN-6 Investigators
Apr 11, 2018·Gastroenterología y hepatología·Rocío AllerManuel Romero-Gómez
Mar 13, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Qian-Hua FangBei Sun
Jun 5, 2020·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Simin FanPeimin Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

MMW Fortschritte der Medizin
Jörn M Schattenberg
Journal of Hepatology
Constance E Ruhl, James E Everhart
Lancet
Elizabeth E PowellMary Rinella
© 2021 Meta ULC. All rights reserved